| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | TRPM6 TNIK MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 ATM MAPK4 EIF2AK1 ALPK2 | 1.78e-06 | 363 | 187 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | LIMA1 ANK2 MAP7D3 KNSTRN SYNE1 SPTAN1 SPTB OBSCN LMTK2 PHF6 PSMD10 CDC42EP3 SMTN STIM1 CCDC88C TTBK2 BICDL1 CCDC66 ALMS1 ARHGEF10 STARD9 KIF19 CCSER2 MACF1 KIF18B CNGA3 MAPK8IP2 | 4.21e-06 | 1099 | 187 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRPM6 TNIK MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 ATM MAPK4 EIF2AK1 ALPK2 | 2.10e-05 | 446 | 187 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | microtubule binding | MAP7D3 KNSTRN STIM1 CCDC88C TTBK2 CCDC66 ALMS1 STARD9 KIF19 CCSER2 MACF1 KIF18B | 3.53e-05 | 308 | 187 | 12 | GO:0008017 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGEF28 ARHGAP23 ASAP3 OBSCN DOCK10 RALGAPA2 ARHGEF11 TIAM2 CCDC88C ARHGAP22 RASAL3 ARHGEF10 AKAP13 HERC2 ARHGAP21 | 9.01e-05 | 507 | 187 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGEF28 ARHGAP23 ASAP3 OBSCN DOCK10 RALGAPA2 ARHGEF11 TIAM2 CCDC88C ARHGAP22 RASAL3 ARHGEF10 AKAP13 HERC2 ARHGAP21 | 9.01e-05 | 507 | 187 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | protein kinase activity | TRPM6 TNIK DDR1 MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 ATM MAPK4 EIF2AK1 ALPK2 | 1.74e-04 | 600 | 187 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | tubulin binding | MAP7D3 KNSTRN PHF6 STIM1 CCDC88C TTBK2 CCDC66 ALMS1 STARD9 KIF19 CCSER2 MACF1 KIF18B | 2.07e-04 | 428 | 187 | 13 | GO:0015631 |
| GeneOntologyMolecularFunction | protein kinase A binding | 2.09e-04 | 58 | 187 | 5 | GO:0051018 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.46e-04 | 60 | 187 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | ARHGEF28 OBSCN DOCK10 ARHGEF11 TIAM2 CCDC88C ARHGEF10 AKAP13 HERC2 | 3.39e-04 | 231 | 187 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRPM6 TNIK DDR1 MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 PIK3C2B ATM MAPK4 EIF2AK1 ALPK2 | 3.78e-04 | 709 | 187 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 8.29e-04 | 78 | 187 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | kinase activity | TRPM6 TNIK DDR1 MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 PIK3C2B ATM MAPK4 EIF2AK1 ALPK2 | 8.72e-04 | 764 | 187 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.09e-03 | 22 | 187 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.29e-03 | 86 | 187 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.32e-03 | 51 | 187 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.43e-03 | 88 | 187 | 5 | GO:0140034 | |
| GeneOntologyMolecularFunction | kinesin binding | 1.75e-03 | 55 | 187 | 4 | GO:0019894 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.75e-03 | 55 | 187 | 4 | GO:0061733 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 5.95e-06 | 144 | 184 | 9 | GO:0051261 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CACNA1E MAP7D3 STAG1 KNSTRN ASH1L PDCL2 ARMC2 LYST WDR47 CCDC88C CEP68 TTBK2 BICDL1 KAT2B CCDC66 ALMS1 LMNA ARHGEF10 INSC STARD9 KIF19 CCSER2 MACF1 KIF18B ARHGAP21 | 8.37e-06 | 1058 | 184 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | AKAP6 LIMA1 CARMIL2 ANK2 SPTAN1 SPTB ASAP3 NAA80 CDC42EP3 RYR2 FCHSD2 ALMS1 ARHGEF10 TJP1 AKAP13 | 9.62e-06 | 438 | 184 | 15 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | LIMA1 CARMIL2 SPTAN1 SPTB ASAP3 NAA80 CDC42EP3 WDR47 CCDC88C TTBK2 FCHSD2 ALMS1 ARHGEF10 TJP1 AKAP13 | 9.62e-06 | 438 | 184 | 15 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGEF28 ARHGAP23 DOK7 OBSCN RALGAPA2 ARHGEF11 TIAM2 ARHGAP22 RASAL3 ARHGEF10 AUTS2 AKAP13 ARHGAP21 | 9.73e-06 | 333 | 184 | 13 | GO:0051056 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.49e-05 | 89 | 184 | 7 | GO:1901880 | |
| GeneOntologyBiologicalProcess | actin filament-based process | AKAP6 TNIK LIMA1 CARMIL2 ANK2 SPTAN1 SPTB ASAP3 OBSCN NAA80 ARHGEF11 CDC42BPB CDC42EP3 RYR2 SMTN CCDC88C FCHSD2 ALMS1 ARHGEF10 TJP1 AUTS2 AKAP13 | 2.23e-05 | 912 | 184 | 22 | GO:0030029 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP7D3 STAG1 KNSTRN PDCL2 ARMC2 WDR47 CCDC88C CEP68 TTBK2 KAT2B CCDC66 ALMS1 LMNA ARHGEF10 INSC STARD9 KIF19 CCSER2 KIF18B | 2.51e-05 | 720 | 184 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ARHGEF28 ARHGAP23 DOK7 OBSCN DOCK10 RALGAPA2 ARHGEF11 CDC42EP3 TIAM2 CCDC88C ARHGAP22 RASAL3 ARHGEF10 AUTS2 AKAP13 ARHGAP21 | 2.75e-05 | 538 | 184 | 16 | GO:0007264 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.19e-05 | 100 | 184 | 7 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 4.37e-05 | 105 | 184 | 7 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 6.35e-05 | 194 | 184 | 9 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | LIMA1 CARMIL2 SPTAN1 SPTB ASAP3 NAA80 CDC42EP3 WDR47 CCDC88C TTBK2 FCHSD2 KAT2B ALMS1 ARHGEF10 TJP1 AKAP13 | 6.58e-05 | 579 | 184 | 16 | GO:0051493 |
| GeneOntologyBiologicalProcess | protein localization to M-band | 7.92e-05 | 2 | 184 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | LIMA1 CARMIL2 SPTAN1 SPTB ASAP3 NAA80 CDC42EP3 FCHSD2 ALMS1 ARHGEF10 TJP1 | 8.37e-05 | 300 | 184 | 11 | GO:0110053 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | LIMA1 CARMIL2 SPTAN1 SPTB MARCHF7 PSMD10 WDR47 CCDC88C TTBK2 KAT2B LMNA TJP1 ATM | 1.09e-04 | 421 | 184 | 13 | GO:0010639 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | LIMA1 CARMIL2 MAP7D3 SPTAN1 SPTB ASAP3 OBSCN NAA80 CDC42EP3 WDR47 CCDC88C TTBK2 FCHSD2 ALMS1 ARHGEF10 TJP1 ACAN KIF19 AKAP13 KIF18B NUP153 | 1.33e-04 | 957 | 184 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | LIMA1 CARMIL2 SYNE1 SPTAN1 SPTB ASAP3 MARCHF7 NAA80 PSMD10 SMG5 CDC42EP3 WDR47 CCDC88C TTBK2 FCHSD2 KAT2B VPS13D ALMS1 LMNA ARHGEF10 ANAPC1 TJP1 AKAP13 ATM EIF2AK1 TASOR | 1.55e-04 | 1342 | 184 | 26 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | LIMA1 CARMIL2 SPTAN1 SPTB ASAP3 NAA80 CDC42EP3 FCHSD2 ALMS1 ARHGEF10 TJP1 AKAP13 | 1.80e-04 | 384 | 184 | 12 | GO:0032956 |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 2.36e-04 | 3 | 184 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 2.36e-04 | 3 | 184 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | LIMA1 CARMIL2 SPTAN1 SPTB ATAD2 WDR47 CCDC88C TTBK2 KIF19 KIF18B | 2.96e-04 | 291 | 184 | 10 | GO:0032984 |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 3.08e-04 | 66 | 184 | 5 | GO:0007019 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 3.15e-04 | 144 | 184 | 7 | GO:0043244 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TNIK LIMA1 CARMIL2 SPTAN1 SPTB ASAP3 OBSCN NAA80 ARHGEF11 CDC42BPB CDC42EP3 SMTN FCHSD2 ALMS1 ARHGEF10 TJP1 AUTS2 AKAP13 | 3.17e-04 | 803 | 184 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | ANKRD31 STAG1 KNSTRN TEX15 IHO1 KAT2B ARHGEF10 ANAPC1 ATM KIF18B STAG3 | 3.69e-04 | 356 | 184 | 11 | GO:0098813 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 3.95e-04 | 39 | 184 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 4.01e-04 | 197 | 184 | 8 | GO:1902904 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | DDR1 LIMA1 CARMIL2 SPTAN1 SPTB ERN2 ATAD2 WDR47 CCDC88C TTBK2 VPS13D KIF19 EIF2AK1 KIF18B CX3CR1 | 4.41e-04 | 617 | 184 | 15 | GO:0022411 |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 4.69e-04 | 4 | 184 | 2 | GO:0098910 | |
| Domain | PH_dom-like | ARHGEF28 ARHGAP23 NBEAL1 DOK7 ASAP3 OBSCN DOCK10 ARHGEF11 LYST CDC42BPB TIAM2 ARHGAP22 RASAL3 ARHGEF10 OSBPL7 AKAP13 ARHGAP21 MAPK8IP2 ANKS1A | 4.19e-08 | 426 | 183 | 19 | IPR011993 |
| Domain | PH | ARHGEF28 ARHGAP23 DOK7 ASAP3 OBSCN DOCK10 ARHGEF11 CDC42BPB TIAM2 ARHGAP22 RASAL3 OSBPL7 AKAP13 ARHGAP21 | 6.52e-07 | 278 | 183 | 14 | SM00233 |
| Domain | PH_DOMAIN | ARHGEF28 ARHGAP23 DOK7 ASAP3 OBSCN DOCK10 ARHGEF11 CDC42BPB TIAM2 ARHGAP22 RASAL3 OSBPL7 AKAP13 ARHGAP21 | 6.81e-07 | 279 | 183 | 14 | PS50003 |
| Domain | PH_domain | ARHGEF28 ARHGAP23 DOK7 ASAP3 OBSCN DOCK10 ARHGEF11 CDC42BPB TIAM2 ARHGAP22 RASAL3 OSBPL7 AKAP13 ARHGAP21 | 7.10e-07 | 280 | 183 | 14 | IPR001849 |
| Domain | - | ARHGEF28 ARHGAP23 DOK7 ASAP3 OBSCN DOCK10 ARHGEF11 CDC42BPB TIAM2 ARHGAP22 RASAL3 OSBPL7 AKAP13 ARHGAP21 MAPK8IP2 ANKS1A | 1.60e-06 | 391 | 183 | 16 | 2.30.29.30 |
| Domain | Kinase-like_dom | TRPM6 TNIK DDR1 MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 PIK3C2B MACF1 ATM MAPK4 EIF2AK1 ALPK2 | 6.67e-06 | 542 | 183 | 18 | IPR011009 |
| Domain | SPEC | 1.39e-05 | 32 | 183 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.39e-05 | 32 | 183 | 5 | IPR018159 | |
| Domain | DH_1 | 3.48e-05 | 63 | 183 | 6 | PS00741 | |
| Domain | RhoGEF | 5.39e-05 | 68 | 183 | 6 | SM00325 | |
| Domain | RhoGEF | 6.35e-05 | 70 | 183 | 6 | PF00621 | |
| Domain | DH_2 | 6.35e-05 | 70 | 183 | 6 | PS50010 | |
| Domain | Spectrin | 6.83e-05 | 23 | 183 | 4 | PF00435 | |
| Domain | - | 6.88e-05 | 71 | 183 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 6.88e-05 | 71 | 183 | 6 | IPR000219 | |
| Domain | SPIN-2 | 9.55e-05 | 2 | 183 | 2 | IPR029564 | |
| Domain | AKAP6/CEP68 | 9.55e-05 | 2 | 183 | 2 | IPR026696 | |
| Domain | Filaggrin | 9.55e-05 | 2 | 183 | 2 | IPR003303 | |
| Domain | Spectrin_repeat | 1.75e-04 | 29 | 183 | 4 | IPR002017 | |
| Domain | AUTS2 | 2.85e-04 | 3 | 183 | 2 | IPR023246 | |
| Domain | CH | 4.39e-04 | 65 | 183 | 5 | SM00033 | |
| Domain | PH | ASAP3 OBSCN DOCK10 CDC42BPB TIAM2 ARHGAP22 OSBPL7 AKAP13 ARHGAP21 | 4.40e-04 | 229 | 183 | 9 | PF00169 |
| Domain | EF_HAND_2 | 4.68e-04 | 231 | 183 | 9 | PS50222 | |
| Domain | EF_hand_dom | 4.83e-04 | 232 | 183 | 9 | IPR002048 | |
| Domain | ARM-type_fold | PPP4R1 STAG1 NBEAL1 RALGAPA2 ARMC2 LYST FOCAD PIK3C2B INSC ATM STAG3 | 5.32e-04 | 339 | 183 | 11 | IPR016024 |
| Domain | GDS_CDC24_CS | 5.61e-04 | 39 | 183 | 4 | IPR001331 | |
| Domain | SCD | 5.66e-04 | 4 | 183 | 2 | PS51425 | |
| Domain | SCD | 5.66e-04 | 4 | 183 | 2 | IPR020839 | |
| Domain | STAG | 5.66e-04 | 4 | 183 | 2 | PF08514 | |
| Domain | STAG | 5.66e-04 | 4 | 183 | 2 | IPR013721 | |
| Domain | PIN_4 | 5.66e-04 | 4 | 183 | 2 | PF13638 | |
| Domain | PROTEIN_KINASE_ATP | TNIK DDR1 MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 MAPK4 EIF2AK1 | 6.13e-04 | 459 | 183 | 13 | PS00107 |
| Domain | CH | 6.18e-04 | 70 | 183 | 5 | PF00307 | |
| Domain | - | 6.19e-04 | 40 | 183 | 4 | 3.40.630.30 | |
| Domain | - | 6.60e-04 | 71 | 183 | 5 | 1.10.418.10 | |
| Domain | CH | 7.49e-04 | 73 | 183 | 5 | PS50021 | |
| Domain | CH-domain | 8.48e-04 | 75 | 183 | 5 | IPR001715 | |
| Domain | S_TKc | TNIK MAP3K14 OBSCN SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 MAPK4 EIF2AK1 | 8.53e-04 | 359 | 183 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | TNIK MAP3K14 OBSCN SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 MAPK4 EIF2AK1 | 9.13e-04 | 362 | 183 | 11 | PS00108 |
| Domain | SPIN/Ssty | 9.36e-04 | 5 | 183 | 2 | IPR003671 | |
| Domain | Spin-Ssty | 9.36e-04 | 5 | 183 | 2 | PF02513 | |
| Domain | Acyl_CoA_acyltransferase | 9.71e-04 | 45 | 183 | 4 | IPR016181 | |
| Domain | Prot_kinase_dom | TNIK DDR1 MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 MAPK4 EIF2AK1 | 1.10e-03 | 489 | 183 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TNIK DDR1 MAP3K14 OBSCN LMTK2 SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 MAPK4 EIF2AK1 | 1.18e-03 | 493 | 183 | 13 | PS50011 |
| Domain | Pkinase | TNIK MAP3K14 OBSCN SRPK2 LRRK1 ERN2 CDC42BPB TTBK2 MAST4 MAPK4 EIF2AK1 | 1.38e-03 | 381 | 183 | 11 | PF00069 |
| Domain | Alpha_kinase | 1.40e-03 | 6 | 183 | 2 | PF02816 | |
| Domain | PIN_dom | 1.40e-03 | 6 | 183 | 2 | IPR002716 | |
| Domain | PH_BEACH | 1.40e-03 | 6 | 183 | 2 | PF14844 | |
| Domain | MHCK_EF2_kinase | 1.40e-03 | 6 | 183 | 2 | IPR004166 | |
| Domain | PINc | 1.40e-03 | 6 | 183 | 2 | SM00670 | |
| Domain | ALPHA_KINASE | 1.40e-03 | 6 | 183 | 2 | PS51158 | |
| Domain | Alpha_kinase | 1.40e-03 | 6 | 183 | 2 | SM00811 | |
| Domain | ACTININ_2 | 1.42e-03 | 23 | 183 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.42e-03 | 23 | 183 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.42e-03 | 23 | 183 | 3 | IPR001589 | |
| Domain | Acetyltransf_1 | 1.42e-03 | 23 | 183 | 3 | PF00583 | |
| Domain | GNAT_dom | 1.82e-03 | 25 | 183 | 3 | IPR000182 | |
| Domain | GNAT | 1.82e-03 | 25 | 183 | 3 | PS51186 | |
| Domain | AT_hook | 2.28e-03 | 27 | 183 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.28e-03 | 27 | 183 | 3 | IPR017956 | |
| Domain | PH-BEACH_dom | 2.57e-03 | 8 | 183 | 2 | IPR023362 | |
| Domain | - | 2.57e-03 | 8 | 183 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 2.57e-03 | 8 | 183 | 2 | PS51783 | |
| Domain | PDZ | 2.68e-03 | 141 | 183 | 6 | PF00595 | |
| Domain | Ser/Thr_kinase_AS | TNIK MAP3K14 OBSCN SRPK2 LRRK1 ERN2 CDC42BPB MAST4 MAPK4 EIF2AK1 | 2.81e-03 | 357 | 183 | 10 | IPR008271 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGEF28 ARHGAP23 ACBD5 OBSCN ARHGEF11 ARHGAP22 ARHGEF10 AKAP13 ARHGAP21 | 3.36e-06 | 142 | 120 | 9 | MM15576 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF28 ARHGAP23 SPTAN1 ACBD5 OBSCN DOCK10 ARHGEF11 CDC42BPB CDC42EP3 TIAM2 ARHGAP22 ARHGEF10 AKAP13 SPEN ARHGAP21 | 4.70e-06 | 439 | 120 | 15 | MM15595 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGEF28 ARHGAP23 ACBD5 OBSCN ARHGEF11 ARHGAP22 ARHGEF10 AKAP13 ARHGAP21 | 4.99e-06 | 149 | 120 | 9 | M41805 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF28 ARHGAP23 SPTAN1 ACBD5 OBSCN DOCK10 ARHGEF11 CDC42BPB CDC42EP3 TIAM2 ARHGAP22 ARHGEF10 AKAP13 SPEN ARHGAP21 | 6.33e-06 | 450 | 120 | 15 | M27078 |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.82e-05 | 70 | 120 | 6 | MM15597 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 3.88e-05 | 74 | 120 | 6 | M41807 | |
| Pathway | PID_RHOA_REG_PATHWAY | 4.26e-05 | 46 | 120 | 5 | M68 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 7.76e-05 | 52 | 120 | 5 | MM14743 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCOA2 ARHGEF28 ARHGAP23 SPTAN1 ACBD5 OBSCN DOCK10 ARHGEF11 CDC42BPB CDC42EP3 TIAM2 ARHGAP22 ARHGEF10 AKAP13 SPEN ARHGAP21 | 1.21e-04 | 649 | 120 | 16 | MM15690 |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.43e-04 | 59 | 120 | 5 | M11215 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.99e-04 | 69 | 120 | 5 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 3.20e-04 | 70 | 120 | 5 | M41806 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 3.20e-04 | 70 | 120 | 5 | MM14824 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | DOCK10 ARHGEF11 CDC42BPB CDC42EP3 ARHGAP22 ARHGEF10 ARHGAP21 | 3.57e-04 | 155 | 120 | 7 | M41808 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCOA2 ARHGEF28 ARHGAP23 SPTAN1 ACBD5 OBSCN DOCK10 ARHGEF11 CDC42BPB CDC42EP3 TIAM2 ARHGAP22 ARHGEF10 AKAP13 SPEN ARHGAP21 | 3.92e-04 | 720 | 120 | 16 | M41838 |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 4.69e-04 | 76 | 120 | 5 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 4.98e-04 | 77 | 120 | 5 | MM15044 | |
| Pathway | REACTOME_MEIOSIS | 5.57e-04 | 120 | 120 | 6 | M529 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 5.94e-04 | 80 | 120 | 5 | M800 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.39e-04 | 175 | 120 | 7 | MM15599 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 7.84e-04 | 85 | 120 | 5 | MM14746 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CRTC3 LIMA1 ARHGEF28 CARMIL2 MAP7D3 EXPH5 SPTAN1 MAP3K14 LMTK2 CBARP LYST KIAA1671 STIM1 CCDC88C STOX2 VPS13D MDN1 MAST4 ALMS1 PIK3C2B ARHGEF10 TJP1 PRRC2C STARD9 CCSER2 MACF1 AKAP13 CRYBG3 MAPK4 ARHGAP21 ANKS1A | 1.23e-16 | 861 | 192 | 31 | 36931259 |
| Pubmed | MAP7D3 EXPH5 POM121C KIAA1671 STOX2 UBE2O ALMS1 TJP1 CCSER2 TNRC6A NFX1 MACF1 TMEM131 CRYBG3 ARHGAP21 NUP153 ANKS1A | 1.40e-13 | 263 | 192 | 17 | 34702444 | |
| Pubmed | TNIK NCOA2 CACNA1E LIMA1 ANK2 FOXP2 SYNE1 SPTAN1 SRPK2 BCL11A ARHGEF11 CDC42BPB WDR47 CCDC88C STOX2 UBE2O MDN1 ANAPC1 TJP1 PRRC2C MACF1 HERC2 ARHGAP21 NUP153 AFF4 MAPK8IP2 ANKS1A | 4.81e-12 | 963 | 192 | 27 | 28671696 | |
| Pubmed | AKAP6 NCOA2 PPP4R1 DCHS2 ANK2 STAG1 SYNE1 SPTAN1 SPTB ASH1L SRPK2 SMG5 CDC42BPB DCAF5 WDR47 FOCAD NFE2L3 UBE2O NSMF ARHGEF10 NECAB1 TJP1 MACF1 TMEM131 ATM HERC2 EIF2AK1 HERPUD2 ARHGAP21 AFF4 MAPK8IP2 | 5.15e-12 | 1285 | 192 | 31 | 35914814 | |
| Pubmed | FOXP2 ARHGAP23 FAT3 ASH1L FBRSL1 SRPK2 BCL11A IDH3B RALGAPA2 POM121C PRPF40A DCAF5 NKRF DNTTIP2 KIAA1671 KAT7 KAT2B RASAL3 ALMS1 ANAPC1 TNRC6A MACF1 ELF3 CRYBG3 KIF18B TAF7 KAT14 AFF4 | 2.51e-11 | 1116 | 192 | 28 | 31753913 | |
| Pubmed | NCOA2 FLG LIMA1 FOXP2 SPTAN1 FBRSL1 PHF6 KRI1 SMG5 BCL11A GPATCH8 FLG2 POM121C PRPF40A DCAF5 NKRF KIAA1671 PRR12 KAT2B UBE2O ALMS1 PRRC2C WDCP TNRC6A AUTS2 ELF3 HERC2 SPEN KAT14 NPAT | 3.38e-10 | 1429 | 192 | 30 | 35140242 | |
| Pubmed | AKAP6 TRPM6 NCOA2 ZC3H13 ASH1L OBSCN LMTK2 MARCHF7 PSMD10 GPATCH8 DCAF5 DNTTIP2 TIAM2 SMTN KAT7 ZNF750 TTBK2 CCSER2 NFX1 MACF1 TMEM131 TASOR ARHGAP21 NUP153 AFF4 NPAT | 3.61e-10 | 1084 | 192 | 26 | 11544199 | |
| Pubmed | AKAP6 TNIK SYNE1 DOCK10 SMG5 CDC42BPB CEP68 TENM4 ALMS1 ARHGEF10 AUTS2 MACF1 PCNX1 | 4.53e-10 | 225 | 192 | 13 | 12168954 | |
| Pubmed | TNIK SYNE1 DOCK10 PHF6 BCL11A GPATCH8 DCAF5 WDR47 FOCAD FCHSD2 TENM4 PRRC2C STARD9 MACF1 SPEN ARHGAP21 | 1.22e-09 | 407 | 192 | 16 | 12693553 | |
| Pubmed | CRTC3 EXPH5 CCDC186 SYNE1 SPTAN1 LAMB2 MUC12 ARHGEF11 POM121C CDC42BPB CDC42EP3 RASAL3 TNRC6A MACF1 AKAP13 HERC2 NUP153 | 2.11e-09 | 486 | 192 | 17 | 20936779 | |
| Pubmed | TNIK MAP7D3 KIAA1671 VPS13D UBE2O MAST4 ALMS1 TNRC6A MACF1 CRYBG3 ARHGAP21 ANKS1A | 2.31e-09 | 209 | 192 | 12 | 36779422 | |
| Pubmed | ZC3H13 SPTAN1 KRI1 ATAD2 PRPF40A NKRF DNTTIP2 UBE2O MDN1 LMNA ANAPC1 TJP1 PRRC2C MACF1 ATM HERC2 SPEN MED12 NUP153 | 4.71e-09 | 653 | 192 | 19 | 22586326 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 FOXP2 FBRSL1 BCL11A FLG2 POM121C KIAA1671 PRR12 KAT2B ALMS1 AUTS2 SPEN KAT14 MED12 | 1.14e-08 | 351 | 192 | 14 | 38297188 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | OBSCN FBRSL1 LMTK2 LAMB2 SMG5 LRRK1 RALGAPA2 ARHGEF11 POM121C LYST CDC42BPB TIAM2 FOCAD PRR12 CCDC88C MDN1 PIK3C2B NFX1 PCNX1 AKAP13 HERC2 SPEN ARHGAP21 MED12 | 1.24e-08 | 1105 | 192 | 24 | 35748872 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | LIMA1 MAP7D3 KNSTRN ZC3H13 LMTK2 PRPF40A NKRF KIAA1671 PRR12 STARD9 AKAP13 TMEM131 ARHGAP21 NUP153 | 1.62e-08 | 361 | 192 | 14 | 30344098 |
| Pubmed | ARHGEF28 ARHGAP23 EXPH5 RALGAPA2 POM121C CDC42BPB PRR12 CCDC88C CEP68 VPS13D ALMS1 MACF1 KLHL14 EIF2AK1 TASOR MED12 | 1.82e-08 | 493 | 192 | 16 | 15368895 | |
| Pubmed | SPTAN1 IDH3B UBE2O ALMS1 ATAD1 ANAPC1 PRRC2C WDCP TNRC6A TASOR MED12 | 1.19e-07 | 242 | 192 | 11 | 34011540 | |
| Pubmed | 1.77e-07 | 151 | 192 | 9 | 17043677 | ||
| Pubmed | TNIK ANK2 SYNE1 ZC3H13 SPTAN1 ACBD5 KRI1 SRPK2 CBARP CDC42BPB PRPF40A DCAF5 DNTTIP2 STIM1 UBE2O MDN1 LMNA ARHGEF10 CCSER2 MACF1 AKAP13 TMEM131 ATM CRYBG3 HERC2 NPAT | 2.17e-07 | 1487 | 192 | 26 | 33957083 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK LIMA1 ANK2 MAP7D3 PHF6 POM121C PRPF40A NKRF DNTTIP2 KIAA1671 UBE2O ALMS1 TJP1 PRRC2C MACF1 TASOR ARHGAP21 NUP153 AFF4 ANKS1A | 2.76e-07 | 934 | 192 | 20 | 33916271 |
| Pubmed | AKAP6 FBRSL1 LMTK2 SMG5 LRRK1 TIAM2 STOX2 UBE2O MAST4 CCSER2 TNRC6A AUTS2 PCNX1 CARNS1 ANKS1A | 2.92e-07 | 529 | 192 | 15 | 14621295 | |
| Pubmed | LIMA1 STAG1 SPTAN1 FLG2 PRPF40A PRR12 MDN1 LMNA ANAPC1 STAG3 MED12 | 3.84e-07 | 272 | 192 | 11 | 31010829 | |
| Pubmed | NCOA2 LIMA1 MAP7D3 SPTAN1 PRPF40A NKRF KIAA1671 UBE2O ALMS1 ANAPC1 TJP1 PRRC2C TAF7 SPEN MED12 | 4.67e-07 | 549 | 192 | 15 | 38280479 | |
| Pubmed | Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. | 6.60e-07 | 4 | 192 | 3 | 14593108 | |
| Pubmed | ZNF280D KIAA1671 PRR12 ALMS1 ANAPC1 WDCP TNRC6A CRYBG3 TASOR KAT14 ARHGAP21 MED12 NPAT | 6.65e-07 | 418 | 192 | 13 | 34709266 | |
| Pubmed | 7.97e-07 | 234 | 192 | 10 | 36243803 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | LMTK2 SRPK2 GPATCH8 POM121C NKRF DNTTIP2 LRCH3 LMNA ANAPC1 WDCP CCSER2 HERC2 NUP153 | 1.18e-06 | 440 | 192 | 13 | 34244565 |
| Pubmed | CRTC3 LIMA1 SPTAN1 KRI1 LRCH3 KIAA1671 CCDC88C ALMS1 ANAPC1 TJP1 CCSER2 TNRC6A ANKS1A | 1.37e-06 | 446 | 192 | 13 | 24255178 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TNIK MAP7D3 KNSTRN KRI1 ARHGEF11 KIAA1671 CCDC88C CCDC66 MAST4 ALMS1 TJP1 WDCP TNRC6A NFX1 TMEM131 HERC2 ARHGAP21 ANKS1A | 1.38e-06 | 853 | 192 | 18 | 28718761 |
| Pubmed | FLG CACNA1E LIMA1 ANK2 STAG1 SYNE1 SPTAN1 ASH1L DACT2 LYST DNTTIP2 RYR2 NFE2L3 MDN1 LMNA TJP1 PRRC2C STARD9 MACF1 ATM SPEN USP1 TASOR ARHGAP21 | 1.57e-06 | 1442 | 192 | 24 | 35575683 | |
| Pubmed | 1.89e-06 | 104 | 192 | 7 | 9205841 | ||
| Pubmed | 2.33e-06 | 153 | 192 | 8 | 10718198 | ||
| Pubmed | SYNE1 KRI1 ATAD2 POM121C PRPF40A NKRF DNTTIP2 KAT7 TJP1 TASOR NUP153 | 2.68e-06 | 332 | 192 | 11 | 25693804 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP7D3 SPTAN1 SMG5 CDC42BPB STIM1 ANAPC1 TJP1 PRRC2C TNRC6A NFX1 MACF1 AKAP13 TMEM131 KIF18B TAF7 SPEN | 3.05e-06 | 724 | 192 | 16 | 36232890 |
| Pubmed | NCOA2 MAP7D3 SPTAN1 PHF6 PSMD10 ATAD2 KAT7 KAT2B UBE2O CCDC66 ALMS1 MSL3 KIF18B SPEN MED12 | 3.40e-06 | 645 | 192 | 15 | 25281560 | |
| Pubmed | PPP4R1 ARHGEF28 ARHGAP23 FBRSL1 DOCK10 SRPK2 NKRF PRR12 PRRC2C WDCP AKAP13 CRYBG3 RNF128 TASOR ARHGAP21 | 3.73e-06 | 650 | 192 | 15 | 38777146 | |
| Pubmed | AKAP6 ANK2 SYNE1 SPTB OBSCN CDC42BPB RNF11 DNTTIP2 ALMS1 LMNA MACF1 USP1 ARHGAP21 | 4.45e-06 | 497 | 192 | 13 | 23414517 | |
| Pubmed | LIMA1 CARMIL2 ANK2 ARHGAP23 SYNE1 SPTAN1 SPTB SRPK2 BCL11A IDH3B ARHGEF11 CDC42BPB PRPF40A LRCH3 WDR47 UBE2O TENM4 LMNA TJP1 PRRC2C MACF1 ARHGAP21 MAPK8IP2 | 4.69e-06 | 1431 | 192 | 23 | 37142655 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.92e-06 | 120 | 192 | 7 | 31413325 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CRTC3 ASAP3 POM121C RNF11 KIAA1671 RASAL3 LMNA AKAP13 TSHZ1 ATM SPEN NUP153 | 5.46e-06 | 430 | 192 | 12 | 35044719 |
| Pubmed | TNIK CACNA1E DDR1 ARHGAP23 CDC42BPB WDR47 STARD9 ACAN MACF1 HERC2 ARHGAP21 MAPK8IP2 | 5.46e-06 | 430 | 192 | 12 | 32581705 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOA2 PPP4R1 FBRSL1 KIAA1671 ALMS1 PIK3C2B ANAPC1 PRRC2C WDCP TNRC6A MACF1 CRYBG3 SPEN KAT14 | 5.57e-06 | 588 | 192 | 14 | 38580884 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.80e-06 | 123 | 192 | 7 | 26912792 | |
| Pubmed | PDXDC1 MAP7D3 CCDC186 ACBD5 CBARP FLG2 CDC42BPB CDC42EP3 RYR2 KIAA1671 STIM1 TJP1 TNRC6A SPEN TASOR ARHGAP21 | 7.40e-06 | 777 | 192 | 16 | 35844135 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.10e-06 | 184 | 192 | 8 | 32908313 | |
| Pubmed | SYNE1 ACBD5 PHF6 LAMB2 SRPK2 GPATCH8 ARHGEF11 ATAD2 CDC42BPB NKRF LRCH3 KIAA1671 PRR12 MDN1 ANAPC1 TNRC6A NFX1 MACF1 HERC2 SPEN TASOR MED12 AFF4 | 9.72e-06 | 1497 | 192 | 23 | 31527615 | |
| Pubmed | 1.04e-05 | 25 | 192 | 4 | 38877142 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | PDXDC1 TNIK LRP12 LMTK2 LAMB2 GPATCH8 PRPF40A ATM HERC2 SPEN | 1.06e-05 | 313 | 192 | 10 | 38270169 |
| Pubmed | MTF2 ZNF831 NKRF KAT7 ALMS1 PRRC2C TNRC6A TAF7 SPEN TASOR MUC4 ANKS1A | 1.30e-05 | 469 | 192 | 12 | 27634302 | |
| Pubmed | TNIK GPATCH8 CWC25 UBE2O ALMS1 ATAD1 ARHGEF10 ANAPC1 TJP1 TNRC6A AKAP13 TMEM131 USP1 TASOR ANKS1A | 1.55e-05 | 733 | 192 | 15 | 34672954 | |
| Pubmed | BNC2 LIMA1 SMG5 GPATCH8 PRPF40A KAT7 PRRC2C MACF1 AKAP13 TMEM131 | 1.89e-05 | 335 | 192 | 10 | 15741177 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.93e-05 | 10 | 192 | 3 | 22159418 | |
| Pubmed | TNIK ANK2 SPTAN1 ACBD5 LMTK2 CBARP CDC42BPB RYR2 WDR47 STIM1 UBE2O TENM4 LMNA ATAD1 TJP1 PRRC2C TNRC6A MACF1 CRYBG3 | 2.00e-05 | 1139 | 192 | 19 | 36417873 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 EXPH5 OBSCN ARHGEF11 VPS13D MDN1 PIK3C2B KIF19 ATM MUC4 ARHGAP21 MED12 | 2.30e-05 | 497 | 192 | 12 | 36774506 |
| Pubmed | 2.36e-05 | 274 | 192 | 9 | 34244482 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MAP7D3 ZC3H13 PHF6 KRI1 CWC25 PRPF40A NKRF DNTTIP2 LMNA TJP1 PRRC2C KIF18B SPEN TASOR NUP153 AFF4 NPAT | 2.45e-05 | 954 | 192 | 17 | 36373674 |
| Pubmed | 2.52e-05 | 31 | 192 | 4 | 27321927 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 DDR1 SPTB ASH1L OBSCN FBRSL1 PHF6 EVC SRPK2 KCNIP3 ARMC2 CDC42BPB CDC42EP3 LRCH3 KIAA1671 PTPDC1 TJP1 AUTS2 MACF1 AKAP13 AFF4 ANKS1A | 2.78e-05 | 1489 | 192 | 22 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LIMA1 ZC3H13 SPTAN1 GPATCH8 ATAD2 PRPF40A SMTN MDN1 LMNA ANAPC1 MSL3 ATM SPEN NUP153 ANKS1A | 2.90e-05 | 774 | 192 | 15 | 15302935 |
| Pubmed | Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. | 3.03e-05 | 2 | 192 | 2 | 8789452 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 24193021 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 9199932 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 11801724 | ||
| Pubmed | The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer. | 3.03e-05 | 2 | 192 | 2 | 20374707 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 10579058 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 35597525 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 22665792 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 23707616 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 35660571 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 21156181 | ||
| Pubmed | Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. | 3.03e-05 | 2 | 192 | 2 | 12145692 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 11352932 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 9890967 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 24813994 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 25237101 | ||
| Pubmed | FLG PHF6 SRPK2 IDH3B CDC42BPB LRCH3 KAT7 LMNA ARHGEF10 TJP1 NFX1 MACF1 AKAP13 | 3.29e-05 | 601 | 192 | 13 | 33658012 | |
| Pubmed | LIMA1 TEPSIN SPTAN1 SPTB CDC42BPB CDC42EP3 LMNA TJP1 PRRC2C MACF1 | 3.49e-05 | 360 | 192 | 10 | 33111431 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MAP7D3 MTF2 ZC3H13 GPATCH8 POM121C PRPF40A NKRF DNTTIP2 PRR12 KAT7 MDN1 LMNA ANAPC1 MSL3 KIF18B TAF7 SPEN TASOR KAT14 NUP153 | 3.53e-05 | 1294 | 192 | 20 | 30804502 |
| Pubmed | PDXDC1 MARCHF7 PSMD10 DCAF5 KIAA1671 VPS13D MDN1 ATAD1 ANAPC1 PRRC2C TMEM131 HERC2 ARHGAP21 | 3.58e-05 | 606 | 192 | 13 | 36538041 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF280D STAG1 MTF2 GPATCH8 ATAD2 DNTTIP2 KAT7 UBE2O HERC2 KIF18B SPEN AFF4 NPAT | 3.71e-05 | 608 | 192 | 13 | 36089195 |
| Pubmed | A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. | 4.55e-05 | 13 | 192 | 3 | 21079607 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | LIMA1 MAP7D3 KRI1 MARCHF7 FLG2 PRPF40A LRCH3 KIAA1671 MDN1 PRRC2C USP1 MED12 NUP153 | 4.83e-05 | 624 | 192 | 13 | 33729478 |
| Pubmed | 4.94e-05 | 233 | 192 | 8 | 37704626 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 CRTC3 GPATCH8 POM121C PRPF40A PRR12 LMNA PRRC2C TNRC6A AUTS2 NUP153 | 5.21e-05 | 457 | 192 | 11 | 32344865 |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 5.74e-05 | 38 | 192 | 4 | 11756498 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.77e-05 | 180 | 192 | 7 | 35198878 | |
| Pubmed | PPP4R1 SPTAN1 ACBD5 LMTK2 KRI1 CBARP PSMD10 CDC42BPB KIAA1671 STIM1 PTPDC1 TJP1 TNRC6A CRYBG3 HERC2 USP1 NUP153 | 7.90e-05 | 1049 | 192 | 17 | 27880917 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 8.22e-05 | 322 | 192 | 9 | 39098523 | |
| Pubmed | PDXDC1 LIMA1 NBEAL1 SPTAN1 ACBD5 STIM1 VPS13D LMNA TJP1 PRRC2C TMEM131 NUP153 | 8.29e-05 | 568 | 192 | 12 | 37774976 | |
| Pubmed | 8.85e-05 | 130 | 192 | 6 | 12421765 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 9.06e-05 | 3 | 192 | 2 | 29730765 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 10814726 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 8781769 | ||
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 9.06e-05 | 3 | 192 | 2 | 28928464 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 21050672 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 27005929 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 31235574 | ||
| Pubmed | Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. | 9.06e-05 | 3 | 192 | 2 | 18782775 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 32437351 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 28554271 | ||
| Interaction | SFN interactions | TNIK CRTC3 LIMA1 ARHGEF28 MAP7D3 EXPH5 SPTAN1 LMTK2 CBARP LYST KIAA1671 KAT7 CCDC88C STOX2 MAST4 ALMS1 LMNA PIK3C2B ARHGEF10 TJP1 PRRC2C CCSER2 MACF1 AKAP13 CRYBG3 ARHGAP21 ANKS1A | 2.79e-10 | 692 | 187 | 27 | int:SFN |
| Interaction | YWHAG interactions | CRTC3 LIMA1 ARHGEF28 CARMIL2 MAP7D3 ARHGAP23 EXPH5 ZC3H13 SPTAN1 LMTK2 CBARP LYST PRPF40A DNTTIP2 LRCH3 KIAA1671 STIM1 CCDC88C PTPDC1 STOX2 VPS13D MDN1 MAST4 ALMS1 LMNA PIK3C2B TJP1 PRRC2C STARD9 CCSER2 OSBPL7 MACF1 AKAP13 ARHGAP21 CFAP410 ANKS1A | 9.78e-10 | 1248 | 187 | 36 | int:YWHAG |
| Interaction | YWHAH interactions | NCOA2 CRTC3 LIMA1 ARHGEF28 CARMIL2 MAP7D3 EXPH5 ZC3H13 SPTAN1 LMTK2 CBARP LYST KIAA1671 STIM1 CCDC88C PTPDC1 STOX2 VPS13D MAST4 ALMS1 PIK3C2B TJP1 PRRC2C STARD9 CCSER2 MACF1 AKAP13 CRYBG3 ARHGAP21 CFAP410 ANKS1A | 3.05e-08 | 1102 | 187 | 31 | int:YWHAH |
| Interaction | MAPRE3 interactions | MAP7D3 KNSTRN MARCHF7 KIAA1671 STIM1 TTBK2 CCDC66 MAST4 KIF19 CCSER2 MACF1 TMEM131 KIF18B ARHGAP21 | 3.33e-08 | 230 | 187 | 14 | int:MAPRE3 |
| Interaction | RNF43 interactions | MAP7D3 EXPH5 OBSCN POM121C KIAA1671 STOX2 UBE2O ALMS1 TJP1 CCSER2 TNRC6A NFX1 MACF1 TMEM131 CRYBG3 ARHGAP21 NUP153 ANKS1A | 1.02e-07 | 427 | 187 | 18 | int:RNF43 |
| Interaction | YWHAQ interactions | CRTC3 LIMA1 ARHGEF28 CARMIL2 MAP7D3 ZNF280D ARHGAP23 EXPH5 ZC3H13 SPTB CBARP LYST RNF11 KIAA1671 CCDC88C PTPDC1 STOX2 VPS13D MAST4 LMNA PIK3C2B TJP1 STARD9 CCSER2 NFX1 MACF1 AKAP13 ARHGAP21 CFAP410 ANKS1A | 1.47e-07 | 1118 | 187 | 30 | int:YWHAQ |
| Interaction | MAPRE1 interactions | LIMA1 MAP7D3 KNSTRN SPTAN1 MARCHF7 SRPK2 STIM1 TTBK2 KAT2B MAST4 ALMS1 PRRC2C CCSER2 MACF1 TMEM131 HERC2 KIF18B ARHGAP21 NUP153 | 3.40e-07 | 514 | 187 | 19 | int:MAPRE1 |
| Interaction | YWHAZ interactions | CRTC3 LIMA1 ARHGEF28 CARMIL2 MAP7D3 EXPH5 SPTAN1 CBARP IDH3B LYST KIAA1671 STIM1 CCDC88C PTPDC1 STOX2 VPS13D MAST4 RASAL3 LMNA PIK3C2B TJP1 STARD9 CCSER2 NFX1 OSBPL7 MACF1 AKAP13 ATM HERC2 ARHGAP21 CFAP410 ANKS1A | 5.13e-07 | 1319 | 187 | 32 | int:YWHAZ |
| Interaction | YWHAB interactions | CRTC3 LIMA1 ARHGEF28 CARMIL2 MAP7D3 ARHGAP23 EXPH5 SPTAN1 SRPK2 CBARP LYST KIAA1671 STIM1 CCDC88C PTPDC1 STOX2 VPS13D MAST4 PIK3C2B TJP1 STARD9 CCSER2 MACF1 AKAP13 ARHGAP21 CFAP410 ANKS1A | 7.76e-07 | 1014 | 187 | 27 | int:YWHAB |
| Interaction | RAPGEF5 interactions | 1.35e-06 | 60 | 187 | 7 | int:RAPGEF5 | |
| Interaction | NUP43 interactions | LRP12 ZNF280D ZC3H13 ASH1L KRI1 GPATCH8 ATAD2 POM121C NKRF DNTTIP2 RYR2 SMTN STIM1 LMNA PRRC2C CCSER2 SPEN MED12 NUP153 NPAT | 1.56e-06 | 625 | 187 | 20 | int:NUP43 |
| Interaction | ANK3 interactions | TNIK ANK2 SPTAN1 SPTB SRPK2 SMG5 LRCH3 ARHGAP22 PIK3R5 ARHGAP21 MAPK8IP2 | 2.91e-06 | 201 | 187 | 11 | int:ANK3 |
| Interaction | PPP1CC interactions | TNIK LIMA1 MAP7D3 KNSTRN ZC3H13 LMTK2 CBARP PRPF40A NKRF RYR2 KIAA1671 PRR12 UBE2O LMNA STARD9 NFX1 AKAP13 TMEM131 ATM ARHGAP21 NUP153 | 5.33e-06 | 738 | 187 | 21 | int:PPP1CC |
| Interaction | SIRT7 interactions | ZC3H13 SPTAN1 KRI1 ATAD2 PRPF40A DCAF5 NKRF DNTTIP2 KAT2B UBE2O MDN1 LMNA ANAPC1 TJP1 PRRC2C MACF1 ATM HERC2 SPEN MED12 NUP153 | 6.03e-06 | 744 | 187 | 21 | int:SIRT7 |
| Interaction | RAPGEFL1 interactions | 6.46e-06 | 29 | 187 | 5 | int:RAPGEFL1 | |
| Interaction | CEP120 interactions | 6.57e-06 | 106 | 187 | 8 | int:CEP120 | |
| Interaction | GSK3A interactions | TNIK MAP7D3 SRPK2 ARHGEF11 PRPF40A KIAA1671 VPS13D UBE2O MDN1 MAST4 ALMS1 TNRC6A MACF1 CRYBG3 ARHGAP21 ANKS1A | 7.24e-06 | 464 | 187 | 16 | int:GSK3A |
| Interaction | CEP135 interactions | MAP7D3 KIAA1671 CCDC88C CCDC66 ALMS1 PIK3C2B TJP1 CCSER2 TNRC6A TMEM131 HERC2 ARHGAP21 | 9.42e-06 | 272 | 187 | 12 | int:CEP135 |
| Interaction | ARHGEF12 interactions | ARHGEF28 ARHGAP23 ARHGEF11 ALMS1 ARHGEF10 ANAPC1 AKAP13 HERC2 | 1.36e-05 | 117 | 187 | 8 | int:ARHGEF12 |
| Interaction | PCNT interactions | AKAP6 KNSTRN SYNE1 SPTAN1 ACBD5 KIAA1671 CEP68 ALMS1 NECAB1 MACF1 ARHGAP21 | 1.63e-05 | 241 | 187 | 11 | int:PCNT |
| Interaction | SYNE3 interactions | EXPH5 POM121C PRPF40A KIAA1671 STIM1 CCDC66 ALMS1 ANAPC1 WDCP CCSER2 TNRC6A MACF1 TMEM131 CRYBG3 ARHGAP21 | 1.79e-05 | 444 | 187 | 15 | int:SYNE3 |
| Interaction | CEP104 interactions | 1.92e-05 | 89 | 187 | 7 | int:CEP104 | |
| Interaction | SIRT6 interactions | FAT3 LMTK2 SRPK2 GPATCH8 POM121C NKRF DNTTIP2 LRCH3 ARHGAP22 LMNA ANAPC1 WDCP CCSER2 HERC2 MED12 MUTYH NUP153 ANKS1A | 2.36e-05 | 628 | 187 | 18 | int:SIRT6 |
| Interaction | MYCBP2 interactions | TNIK LIMA1 ANK2 SPTAN1 SRPK2 ARHGEF11 MDN1 TJP1 PRRC2C MACF1 HERC2 ARHGAP21 ALPK2 | 2.88e-05 | 355 | 187 | 13 | int:MYCBP2 |
| Interaction | YWHAE interactions | CRTC3 LIMA1 ARHGEF28 CARMIL2 MAP7D3 EXPH5 SPTAN1 CBARP LYST LRCH3 KIAA1671 STIM1 CCDC88C ZNF750 PTPDC1 STOX2 UBE2O MAST4 RASAL3 PIK3C2B CCSER2 NFX1 MACF1 AKAP13 ARHGAP21 CFAP410 ANKS1A | 3.88e-05 | 1256 | 187 | 27 | int:YWHAE |
| Interaction | ODF2 interactions | 1.16e-04 | 158 | 187 | 8 | int:ODF2 | |
| Interaction | BMI1 interactions | CDKN3 LIMA1 MTF2 SYNE1 ZC3H13 PHF6 SRPK2 GPATCH8 NKRF KAT2B LMNA PRRC2C NFX1 ATM SPEN TASOR MED12 | 1.45e-04 | 659 | 187 | 17 | int:BMI1 |
| Interaction | GSK3B interactions | TNIK MAP7D3 MTF2 KRI1 ARHGEF11 KIAA1671 NFE2L3 VPS13D UBE2O MAST4 ALMS1 LMNA TJP1 PRRC2C TNRC6A MACF1 CRYBG3 HERC2 ARHGAP21 ANKS1A | 1.71e-04 | 868 | 187 | 20 | int:GSK3B |
| Cytoband | Xp11.1 | 1.04e-04 | 4 | 192 | 2 | Xp11.1 | |
| Cytoband | 11q22-q23 | 2.58e-04 | 6 | 192 | 2 | 11q22-q23 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | ARHGAP23 SPTB ASAP3 DOCK10 TIAM2 ARHGAP22 OSBPL7 AKAP13 ARHGAP21 | 4.67e-06 | 206 | 110 | 9 | 682 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.06e-05 | 66 | 110 | 5 | 722 | |
| GeneFamily | EF-hand domain containing | 5.79e-05 | 219 | 110 | 8 | 863 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.40e-04 | 17 | 110 | 3 | 486 | |
| GeneFamily | CDC14 phosphatases | 2.18e-04 | 4 | 110 | 2 | 900 | |
| GeneFamily | PDZ domain containing | 3.34e-04 | 152 | 110 | 6 | 1220 | |
| GeneFamily | Tudor domain containing|Spindlin family | 3.62e-04 | 5 | 110 | 2 | 1089 | |
| GeneFamily | GCN5 related N-acetyltransferases | 4.04e-04 | 24 | 110 | 3 | 1134 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.57e-04 | 25 | 110 | 3 | 775 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.55e-04 | 7 | 110 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 7.55e-04 | 7 | 110 | 2 | 1350 | |
| GeneFamily | Cohesin complex | 1.00e-03 | 8 | 110 | 2 | 1060 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.28e-03 | 9 | 110 | 2 | 1230 | |
| GeneFamily | Tudor domain containing | 1.46e-03 | 37 | 110 | 3 | 780 | |
| GeneFamily | PHD finger proteins | 2.22e-03 | 90 | 110 | 4 | 88 | |
| GeneFamily | ATAC complex | 2.74e-03 | 13 | 110 | 2 | 1058 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.75e-03 | 46 | 110 | 3 | 622 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.49e-03 | 50 | 110 | 3 | 721 | |
| GeneFamily | AAA ATPases | 4.12e-03 | 53 | 110 | 3 | 413 | |
| GeneFamily | Cadherin related | 4.70e-03 | 17 | 110 | 2 | 24 | |
| GeneFamily | CD molecules|Mucins | 7.14e-03 | 21 | 110 | 2 | 648 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 7.83e-03 | 22 | 110 | 2 | 579 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MAP7D3 SYNE1 SPTAN1 ASH1L DOCK10 KRI1 MARCHF7 GPATCH8 ZNF831 LYST CDC42EP3 PRPF40A DCAF5 DNTTIP2 STIM1 CCDC88C KAT2B RASAL3 CCSER2 AUTS2 MACF1 PCNX1 AKAP13 ATM TAF7 HERPUD2 SPEN USP1 TASOR PIK3R5 NUP153 NPAT | 2.93e-08 | 1492 | 189 | 32 | M40023 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | AKAP6 CACNA1E EXPH5 SPTB ASH1L ASAP3 OBSCN LMTK2 TEX15 ARHGEF11 CWC25 ATAD2 LYST CDC42EP3 SMTN MAST4 LMNA ACAN MSL3 AKAP13 MUC4 STAG3 CFAP410 NPAT | 4.52e-08 | 909 | 189 | 24 | M41018 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 STAG1 MTF2 MAP3K14 MARCHF7 SRPK2 GPATCH8 FCHSD2 MDN1 ARHGEF10 PRRC2C CCSER2 MACF1 AKAP13 TMEM131 CRYBG3 SPEN TASOR NUP153 ANKS1A NPAT | 1.09e-06 | 856 | 189 | 21 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | BNC2 ARHGEF28 ANK2 ZC3H13 ASH1L MAST4 PRRC2C ZNF804B TNRC6A AKAP13 | 5.01e-06 | 221 | 189 | 10 | M39222 |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 7.65e-06 | 38 | 189 | 5 | M39244 | |
| Coexpression | GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP | MAP3K14 FBRSL1 LRRK1 TMEM71 LYST CDC42EP3 CCDC88C STARD9 STAG3 | 1.57e-05 | 200 | 189 | 9 | M7147 |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 1.57e-05 | 200 | 189 | 9 | M9205 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | CACNA1E NEXMIF OBSCN FBRSL1 CDC42BPB BICDL1 STOX2 MDN1 AUTS2 TMEM131 STAG3 MAPK8IP2 | 2.78e-05 | 389 | 189 | 12 | M39102 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STAG1 MTF2 MARCHF7 SRPK2 FCHSD2 MDN1 PRRC2C CCSER2 TMEM131 SPEN TASOR NUP153 ANKS1A | 3.65e-05 | 466 | 189 | 13 | M13522 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | TNIK CRTC3 LIMA1 ZNF280D SYNE1 SPTAN1 SRPK2 ZNF831 FOCAD CEP68 MDN1 PIK3C2B ANAPC1 WDCP CCSER2 MACF1 PCNX1 TSHZ1 ATM NPAT | 4.62e-05 | 1012 | 189 | 20 | M40864 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | SRPK2 LYST PRPF40A CCDC88C TTBK2 CCSER2 AKAP13 ATM HERC2 TASOR CX3CR1 ANKS1A NPAT | 4.63e-05 | 477 | 189 | 13 | M40930 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.12e-05 | 180 | 189 | 8 | M8239 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | NCOA2 MTF2 LYST CDC42EP3 TTBK2 UBE2O ANAPC1 AKAP13 SPEN NPAT | 5.83e-05 | 294 | 189 | 10 | M41112 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 7.21e-05 | 189 | 189 | 8 | M3112 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 8.65e-05 | 194 | 189 | 8 | M8864 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 9.63e-05 | 197 | 189 | 8 | M7403 | |
| Coexpression | GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP | 9.97e-05 | 198 | 189 | 8 | M8162 | |
| Coexpression | GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN | 1.03e-04 | 199 | 189 | 8 | M5065 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP | 1.03e-04 | 199 | 189 | 8 | M3182 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | 1.03e-04 | 199 | 189 | 8 | M4331 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.07e-04 | 200 | 189 | 8 | M8618 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 1.07e-04 | 200 | 189 | 8 | M6513 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN | 1.07e-04 | 200 | 189 | 8 | M5705 | |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.22e-04 | 152 | 189 | 7 | M39243 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DDR1 FOXP2 ARHGAP23 NBEAL1 SYNE1 ACY3 ACBD5 SMG5 KCNIP3 TMEM71 CDC42EP3 FOCAD PTPDC1 ALMS1 PRRC2C PCNX1 HERPUD2 RNF128 CFAP410 MUTYH | 1.47e-04 | 1102 | 189 | 20 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DDR1 FOXP2 ARHGAP23 NBEAL1 SYNE1 ACY3 ACBD5 SMG5 KCNIP3 TMEM71 CDC42EP3 FOCAD PTPDC1 ALMS1 PRRC2C PCNX1 HERPUD2 RNF128 CFAP410 MUTYH | 1.90e-04 | 1124 | 189 | 20 | MM1070 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | MAP7D3 MTF2 MARCHF7 SRPK2 BCL11A RNF11 DNTTIP2 LRCH3 WDR47 STIM1 CEP68 MDN1 NFX1 SPIN2A AUTS2 MACF1 TMEM131 ATM SPIN2B USP1 TASOR | 1.94e-04 | 1215 | 189 | 21 | M41122 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | NCOA2 CDKN3 SYCP2L LRP12 LIMA1 ZNF280D ACBD5 ASH1L FBRSL1 DOCK10 SRPK2 BCL11A KCNIP3 RALGAPA2 ARHGEF11 RNF11 STIM1 CCDC66 WDCP CCSER2 OSBPL7 MACF1 USP1 MUC4 AFF4 MAPK8IP2 | 6.99e-07 | 985 | 189 | 26 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NCOA2 TEPSIN ANK2 ZNF280D FOXP2 SWT1 NEXMIF ZC3H13 FAT3 PHF6 BCL11A KCNIP3 CWC25 PRPF40A LRCH3 WDR47 CCDC88C STOX2 CCDC66 ALMS1 WDCP MACF1 ATM MAPK4 USP1 PIK3R5 CFAP410 | 8.32e-07 | 1060 | 189 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TNIK PPP4R1 BNC2 LIMA1 ZNF280D FOXP2 SWT1 CCDC186 PHF6 MARCHF7 KCNIP3 ATAD2 PRPF40A NKRF LRCH3 FCHSD2 UBE2O CCDC66 MDN1 RASAL3 ALMS1 WDCP SPIN2A TMEM131 ATM USP1 PIK3R5 KAT14 | 6.30e-06 | 1252 | 189 | 28 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NCOA2 SYCP2L TEPSIN ANK2 ZNF280D FOXP2 SWT1 NEXMIF ZC3H13 FAT3 PHF6 BCL11A KCNIP3 CWC25 PRPF40A LRCH3 WDR47 CCDC88C ARHGAP22 STOX2 CCDC66 ALMS1 WDCP MACF1 ATM MAPK4 KLHL14 USP1 PIK3R5 CFAP410 | 7.98e-06 | 1414 | 189 | 30 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | NCOA2 CDKN3 ZNF280D ASH1L SRPK2 BCL11A STIM1 CCDC66 CCSER2 MACF1 USP1 AFF4 | 1.23e-05 | 291 | 189 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PPP4R1 ANK2 ZNF280D FOXP2 SWT1 ZC3H13 PHF6 MARCHF7 BCL11A ATAD2 PRPF40A NKRF DNTTIP2 LRCH3 CCDC88C CCDC66 MDN1 ALMS1 SPIN2A AUTS2 MACF1 ATM RNF128 USP1 PIK3R5 ARHGAP21 MUTYH | 1.93e-05 | 1257 | 189 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PPP4R1 SYCP2L ANK2 ZNF280D FOXP2 SWT1 ZC3H13 PHF6 MARCHF7 BCL11A ATAD2 PRPF40A NKRF DNTTIP2 LRCH3 CCDC88C CCDC66 MDN1 ALMS1 SPIN2A AUTS2 MACF1 ATM MAPK4 RNF128 USP1 PIK3R5 ARHGAP21 MUTYH | 3.84e-05 | 1459 | 189 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | PPP4R1 SYCP2L BNC2 LIMA1 ZNF280D FOXP2 SWT1 CCDC186 PHF6 MARCHF7 BCL11A ATAD2 PRPF40A NKRF DNTTIP2 LRCH3 CCDC66 MDN1 RASAL3 ALMS1 SPIN2A MACF1 TSHZ1 USP1 PIK3R5 | 1.13e-04 | 1241 | 189 | 25 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | LIMA1 ZNF280D FOXP2 CCDC186 SYNE1 BCL11A PRPF40A NKRF FCHSD2 CCDC66 RASAL3 MACF1 TMEM131 | 1.39e-04 | 432 | 189 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | LRP12 ACBD5 FBRSL1 RALGAPA2 ARHGEF11 RNF11 WDCP OSBPL7 MAPK8IP2 | 1.69e-04 | 221 | 189 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | PDXDC1 BNC2 LRP12 LIMA1 FOXP2 DOCK10 PHF6 BCL11A ATAD2 TMEM71 RYR2 TIAM2 NFE2L3 STOX2 TENM4 ANAPC1 WDCP SPIN2A TAF7 | 1.80e-04 | 837 | 189 | 19 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | MORC1 BNC2 MTF2 NBEAL1 NEXMIF ZC3H13 ASH1L TEX15 RYR2 WDR47 PTPDC1 MAST4 ALMS1 ATM TAF7 STAG3 NUP153 NPAT | 2.06e-04 | 776 | 189 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NCOA2 ANK2 ZNF280D ZC3H13 FAT3 SPTAN1 FBRSL1 PHF6 CBARP BCL11A GPATCH8 RALGAPA2 CCDC88C STOX2 KAT2B CCDC66 ALMS1 OSBPL7 AUTS2 ATM MAPK4 KLHL14 KIF18B PIK3R5 ARHGAP21 CFAP410 | 2.11e-04 | 1370 | 189 | 26 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | TNIK NCOA2 STAG1 NBEAL1 ZC3H13 PHF6 PRPF40A VPS13D ALMS1 CCSER2 TMEM131 NPAT | 3.37e-11 | 186 | 192 | 12 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STAG1 NBEAL1 CCDC186 SYNE1 ASH1L LYST CDC42EP3 CCDC88C PRRC2C TAF7 TASOR | 3.58e-10 | 178 | 192 | 11 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.02e-08 | 177 | 192 | 9 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 1.17e-07 | 185 | 192 | 9 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.28e-07 | 187 | 192 | 9 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.40e-07 | 189 | 192 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.47e-07 | 190 | 192 | 9 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-07 | 190 | 192 | 9 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.47e-07 | 190 | 192 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 191 | 192 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 191 | 192 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 191 | 192 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.68e-07 | 193 | 192 | 9 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-07 | 195 | 192 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.00e-07 | 197 | 192 | 9 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-07 | 199 | 192 | 9 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 176 | 192 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.00e-06 | 176 | 192 | 8 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.02e-06 | 122 | 192 | 7 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-06 | 179 | 192 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.24e-06 | 181 | 192 | 8 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.24e-06 | 181 | 192 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-06 | 184 | 192 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.46e-06 | 185 | 192 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.46e-06 | 185 | 192 | 8 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 186 | 192 | 8 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 186 | 192 | 8 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.64e-06 | 188 | 192 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-06 | 189 | 192 | 8 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 189 | 192 | 8 | d05e043d0874b8563b9f5514f6c884b35c603e3a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.71e-06 | 189 | 192 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-06 | 191 | 192 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 191 | 192 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 191 | 192 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.85e-06 | 191 | 192 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 192 | 192 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.92e-06 | 192 | 192 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-06 | 194 | 192 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.16e-06 | 195 | 192 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 2.16e-06 | 195 | 192 | 8 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.42e-06 | 198 | 192 | 8 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.42e-06 | 198 | 192 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 199 | 192 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 2.60e-06 | 200 | 192 | 8 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.60e-06 | 200 | 192 | 8 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.60e-06 | 200 | 192 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.60e-06 | 200 | 192 | 8 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.60e-06 | 200 | 192 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 2.60e-06 | 200 | 192 | 8 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 154 | 192 | 7 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.74e-06 | 162 | 192 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 164 | 192 | 7 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.23e-06 | 170 | 192 | 7 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.23e-06 | 170 | 192 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.59e-06 | 171 | 192 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.96e-06 | 172 | 192 | 7 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 173 | 192 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 173 | 192 | 7 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 173 | 192 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 173 | 192 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 176 | 192 | 7 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 176 | 192 | 7 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 176 | 192 | 7 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 176 | 192 | 7 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-05 | 178 | 192 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 179 | 192 | 7 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.34e-05 | 180 | 192 | 7 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | facs|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 182 | 192 | 7 | 08f775135b451be709f5fc8e1cbcf63425794a2e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 182 | 192 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 183 | 192 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.49e-05 | 183 | 192 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.54e-05 | 184 | 192 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 184 | 192 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 185 | 192 | 7 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.60e-05 | 185 | 192 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 185 | 192 | 7 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 1.60e-05 | 185 | 192 | 7 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 186 | 192 | 7 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 186 | 192 | 7 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 186 | 192 | 7 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 186 | 192 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 192 | 7 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.71e-05 | 187 | 192 | 7 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 192 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.77e-05 | 188 | 192 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 188 | 192 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.77e-05 | 188 | 192 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-05 | 189 | 192 | 7 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 189 | 192 | 7 | b87d586a9570fa54f3e0c6bd4731c5badcaedae6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-05 | 189 | 192 | 7 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.83e-05 | 189 | 192 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 189 | 192 | 7 | 823d6debd09e440ddf36c54af24a5f20e222a21e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 189 | 192 | 7 | 47c2b419b081d5bf75da5e3d9a0e05a70362dfe7 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 189 | 192 | 7 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.83e-05 | 189 | 192 | 7 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 190 | 192 | 7 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 190 | 192 | 7 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.90e-05 | 190 | 192 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-05 | 190 | 192 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.90e-05 | 190 | 192 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.05e-04 | 50 | 102 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | TNIK ARHGEF28 ZNF280D LAMB2 BCL11A ERN2 SMTN CCDC88C VPS13D ATM MED12 | 8.27e-07 | 196 | 190 | 11 | 5827_DN |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | NCOA2 SPTAN1 SMG5 ERN2 LYST CEP68 SLC9A2 NSMF NFX1 ATM EIF2AK1 | 9.61e-07 | 199 | 190 | 11 | 5286_UP |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A | 4.27e-06 | 188 | 190 | 10 | 1865_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | NCOA2 ARHGEF28 MTF2 CCDC186 DOCK10 TTBK2 VPS13D AUTS2 MACF1 PIK3R5 | 6.45e-06 | 197 | 190 | 10 | 7344_UP |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 6.75e-06 | 198 | 190 | 10 | 6211_DN | |
| Drug | Vincristine | CRTC3 LIMA1 ERICH3 STAG1 CCDC186 PHF6 EVC MARCHF7 ATAD2 CDC42EP3 LRCH3 NFE2L3 PRR12 KAT2B VPS13D MDN1 ALMS1 LMNA MACF1 PCNX1 ELF3 TSHZ1 KLHL14 ALPK2 NUP153 | 1.82e-05 | 1182 | 190 | 25 | ctd:D014750 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.42e-05 | 183 | 190 | 9 | 7498_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 3.12e-05 | 189 | 190 | 9 | 3733_DN | |
| Drug | Propofol [2078-54-8]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 3.39e-05 | 191 | 190 | 9 | 3386_DN | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 3.54e-05 | 192 | 190 | 9 | 7536_UP | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.54e-05 | 192 | 190 | 9 | 7378_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 3.83e-05 | 194 | 190 | 9 | 5268_DN | |
| Drug | splitomicin; Up 200; 20uM; PC3; HG-U133A | 3.83e-05 | 194 | 190 | 9 | 661_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 2336_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 7187_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 7200_DN | |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A | 4.49e-05 | 198 | 190 | 9 | 202_DN | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 6486_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A | 4.49e-05 | 198 | 190 | 9 | 2002_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A | 4.49e-05 | 198 | 190 | 9 | 387_DN | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3264_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 190 | 9 | 5207_DN | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 4.67e-05 | 199 | 190 | 9 | 5920_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A | 4.86e-05 | 200 | 190 | 9 | 2905_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 4.86e-05 | 200 | 190 | 9 | 6970_UP | |
| Drug | plakin | 6.46e-05 | 82 | 190 | 6 | CID000018752 | |
| Drug | lithium indium | 6.93e-05 | 2 | 190 | 2 | CID011116062 | |
| Drug | 6-fluorocholesterol | 6.93e-05 | 2 | 190 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 6.93e-05 | 2 | 190 | 2 | CID006454807 | |
| Drug | scandium phosphate | 6.93e-05 | 2 | 190 | 2 | CID006365269 | |
| Drug | rubidium nitrate | 6.93e-05 | 2 | 190 | 2 | CID000025731 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 9.79e-05 | 171 | 190 | 8 | 7535_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.24e-04 | 177 | 190 | 8 | 985_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.24e-04 | 177 | 190 | 8 | 3993_UP | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.29e-04 | 178 | 190 | 8 | 3998_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.45e-04 | 181 | 190 | 8 | 1236_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.51e-04 | 182 | 190 | 8 | 5511_UP | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.02e-04 | 190 | 190 | 8 | 2619_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 2.02e-04 | 190 | 190 | 8 | 4507_DN | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A | 2.02e-04 | 190 | 190 | 8 | 1990_DN | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 2.02e-04 | 190 | 190 | 8 | 4493_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 2.10e-04 | 191 | 190 | 8 | 4283_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.10e-04 | 191 | 190 | 8 | 2824_UP | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.17e-04 | 192 | 190 | 8 | 1792_UP | |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.25e-04 | 193 | 190 | 8 | 4129_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HG-U133A | 2.33e-04 | 194 | 190 | 8 | 428_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.33e-04 | 194 | 190 | 8 | 6833_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.33e-04 | 194 | 190 | 8 | 4763_DN | |
| Drug | Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.33e-04 | 194 | 190 | 8 | 5293_UP | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 2.41e-04 | 195 | 190 | 8 | 449_UP | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 1706_UP | |
| Drug | Florfenicol [73231-34-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 6701_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 3525_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 5359_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 1527_DN | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A | 2.41e-04 | 195 | 190 | 8 | 1290_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A | 2.41e-04 | 195 | 190 | 8 | 1575_UP | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 3524_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; HL60; HG-U133A | 2.50e-04 | 196 | 190 | 8 | 2045_UP | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 5812_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; HL60; HG-U133A | 2.50e-04 | 196 | 190 | 8 | 1735_DN | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 5984_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 4591_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 6988_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.50e-04 | 196 | 190 | 8 | 2889_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 6519_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 7011_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 6061_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 5343_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 3351_UP | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 3267_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 2643_DN | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; PC3; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 5801_DN | |
| Drug | 3-hydroxy-(D/L)-kynurenine; Up 200; 9.2uM; MCF7; HT_HG-U133A_EA | 2.59e-04 | 197 | 190 | 8 | 1109_UP | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.59e-04 | 197 | 190 | 8 | 959_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 1640_DN | |
| Drug | NU1025; Up 200; 100uM; MCF7; HG-U133A | 2.59e-04 | 197 | 190 | 8 | 313_UP | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 1314_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 3515_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 4745_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 4216_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 3528_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 6937_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 6026_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 2.59e-04 | 197 | 190 | 8 | 1240_DN | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; HL60; HG-U133A | 2.67e-04 | 198 | 190 | 8 | 1721_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 6083_DN | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 3537_DN | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 3259_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 4992_DN | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A | 2.67e-04 | 198 | 190 | 8 | 1761_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 6790_DN | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 6464_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; HL60; HG-U133A | 2.67e-04 | 198 | 190 | 8 | 1560_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 7177_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 7526_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; HL60; HG-U133A | 2.67e-04 | 198 | 190 | 8 | 1376_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; PC3; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 5813_DN | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 3482_UP | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.67e-04 | 198 | 190 | 8 | 5345_DN | |
| Disease | cortical surface area measurement | TRPM6 TNIK NCOA2 CDKN3 BNC2 DCHS2 STAG1 FOXP2 NBEAL1 ZC3H13 FAT3 MAP3K14 DOCK10 MARCHF7 SRPK2 CDC42EP3 FOCAD CCDC88C MAST4 TJP1 PRRC2C TNRC6A AUTS2 MACF1 ARHGAP21 ANKS1A | 3.83e-07 | 1345 | 186 | 26 | EFO_0010736 |
| Disease | serum gamma-glutamyl transferase measurement | TNIK STAG1 MTF2 ASH1L ASAP3 LMTK2 ARHGEF11 POM121C CDC42BPB DCAF5 RYR2 NFE2L3 KAT2B SLC9A2 TENM4 TJP1 AKAP13 TSHZ1 ARHGAP21 ALPK2 | 1.49e-06 | 914 | 186 | 20 | EFO_0004532 |
| Disease | cognitive function measurement | AKAP6 NCOA2 PPP4R1 CACNA1E MAP3K14 SRPK2 BCL11A PRR12 ARHGAP22 STOX2 SLC9A2 CCDC66 TENM4 MAST4 ALMS1 ARHGEF10 PRRC2C LRRC53 TNRC6A AUTS2 ZNF799 TMEM131 ARHGAP21 | 3.85e-05 | 1434 | 186 | 23 | EFO_0008354 |
| Disease | Apraxia, Facial-Oral | 3.95e-05 | 2 | 186 | 2 | C0750928 | |
| Disease | Apraxia, Developmental Verbal | 3.95e-05 | 2 | 186 | 2 | C0750927 | |
| Disease | Apraxia, Motor | 3.95e-05 | 2 | 186 | 2 | C0234527 | |
| Disease | Dressing Apraxia | 3.95e-05 | 2 | 186 | 2 | C0234529 | |
| Disease | Ideational Apraxia | 3.95e-05 | 2 | 186 | 2 | C0234526 | |
| Disease | Apraxia, Articulatory | 3.95e-05 | 2 | 186 | 2 | C3495144 | |
| Disease | Apraxia, Oral | 3.95e-05 | 2 | 186 | 2 | C0454608 | |
| Disease | Apraxias | 3.95e-05 | 2 | 186 | 2 | C0003635 | |
| Disease | Apraxia, Verbal | 3.95e-05 | 2 | 186 | 2 | C0349391 | |
| Disease | Apraxia, Gestural | 3.95e-05 | 2 | 186 | 2 | C0422892 | |
| Disease | neuroimaging measurement | PDXDC1 TNIK DCHS2 STAG1 FOXP2 NBEAL1 FAT3 PDCL2 ARHGEF11 POM121C CDC42EP3 CCDC88C ARHGAP22 MAST4 PRRC2C TNRC6A MACF1 KIF18B ANKS1A | 4.98e-05 | 1069 | 186 | 19 | EFO_0004346 |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 TNIK DCHS2 FOXP2 FAT3 PDCL2 GPATCH8 CDC42EP3 CCDC88C MAST4 TNRC6A MACF1 ANKS1A | 5.06e-05 | 550 | 186 | 13 | EFO_0004346, EFO_0004464 |
| Disease | lymphocyte count | TNIK NCOA2 LIMA1 CARMIL2 EXPH5 SPTB DOCK10 ZNF831 ARHGEF11 LYST FOCAD NFE2L3 UBE2O CCDC66 TENM4 RASAL3 ALMS1 ANAPC1 OSBPL7 AUTS2 ATM KLHL14 CX3CR1 | 5.28e-05 | 1464 | 186 | 23 | EFO_0004587 |
| Disease | Apraxia of Phonation | 1.18e-04 | 3 | 186 | 2 | C0264611 | |
| Disease | prostate carcinoma | ANK2 EXPH5 FBRSL1 LMTK2 EVC GPATCH8 ARMC2 CDC42EP3 CCDC88C MAST4 LMNA PIK3C2B INSC TSHZ1 ATM SPEN | 1.78e-04 | 891 | 186 | 16 | EFO_0001663 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.35e-04 | 4 | 186 | 2 | cv:CN293514 | |
| Disease | cortical thickness | AKAP6 TNIK NCOA2 CDKN3 BNC2 FOXP2 NBEAL1 FAT3 CDC42EP3 VPS13D MALRD1 MAST4 TNRC6A AUTS2 MACF1 TMEM131 ARHGAP21 ANKS1A | 2.54e-04 | 1113 | 186 | 18 | EFO_0004840 |
| Disease | colorectal health | 2.99e-04 | 201 | 186 | 7 | EFO_0008460 | |
| Disease | pyruvate measurement | 3.17e-04 | 268 | 186 | 8 | EFO_0010117 | |
| Disease | Heschl's gyrus morphology measurement | 3.52e-04 | 53 | 186 | 4 | EFO_0005852 | |
| Disease | sunburn | 3.63e-04 | 96 | 186 | 5 | EFO_0003958 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 3.90e-04 | 5 | 186 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 3.90e-04 | 5 | 186 | 2 | C0410190 | |
| Disease | ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 | 3.90e-04 | 5 | 186 | 2 | C1832931 | |
| Disease | cognitive function measurement, self reported educational attainment | 4.47e-04 | 355 | 186 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | mean reticulocyte volume | PAQR9 NEXMIF SPTB FBRSL1 BCL11A ARMC2 STIM1 KAT7 KAT2B AKAP13 ATM CARNS1 USP1 ARHGAP21 | 5.77e-04 | 799 | 186 | 14 | EFO_0010701 |
| Disease | Intellectual Disability | AKAP6 CACNA1E MAP7D3 STAG1 SYNE1 ASH1L BCL11A PRR12 MSL3 MACF1 | 5.77e-04 | 447 | 186 | 10 | C3714756 |
| Disease | Emery-Dreifuss muscular dystrophy | 5.83e-04 | 6 | 186 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 5.83e-04 | 6 | 186 | 2 | C0410189 | |
| Disease | N-acetyltyrosine measurement | 5.83e-04 | 6 | 186 | 2 | EFO_0020021 | |
| Disease | N-acetyl-1-methylhistidine measurement | 8.13e-04 | 7 | 186 | 2 | EFO_0800065 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 8.13e-04 | 7 | 186 | 2 | C0751337 | |
| Disease | facial hair thickness measurement | 1.07e-03 | 32 | 186 | 3 | EFO_0007823 | |
| Disease | Large cell carcinoma of lung | 1.07e-03 | 32 | 186 | 3 | C0345958 | |
| Disease | Ischemic stroke | 1.09e-03 | 324 | 186 | 8 | HP_0002140 | |
| Disease | smoking status measurement | MORC1 BNC2 FOXP2 FAT3 LMTK2 TMEM71 CDC42BPB DCAF5 RYR2 FOCAD TENM4 ALMS1 NECAB1 INSC ZNF804B TNRC6A AUTS2 | 1.13e-03 | 1160 | 186 | 17 | EFO_0006527 |
| Disease | HbA1c measurement | TNIK PAQR9 DOK7 SPTB SOX30 ASH1L SMG5 BCL11A FCHSD2 WDCP MACF1 CFAP410 | 1.26e-03 | 675 | 186 | 12 | EFO_0004541 |
| Disease | N-acetylkynurenine (2) measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0800083 | |
| Disease | propionylcarnitine measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0020942 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 1.38e-03 | 9 | 186 | 2 | OBA_2045130 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0800439 | |
| Disease | triglyceride change measurement, response to exercise | 1.38e-03 | 9 | 186 | 2 | EFO_0007681, EFO_0007768 | |
| Disease | Facies | 1.72e-03 | 10 | 186 | 2 | C0282631 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.72e-03 | 10 | 186 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.72e-03 | 10 | 186 | 2 | C1631597 | |
| Disease | alcohol drinking | 1.74e-03 | 81 | 186 | 4 | EFO_0004329 | |
| Disease | systemic lupus erythematosus | NCOA2 PRSS54 FBRSL1 DOCK10 LRRK1 ZNF831 POM121C LYST STIM1 FCHSD2 ZNF804B ELF3 ANKS1A | 1.75e-03 | 799 | 186 | 13 | MONDO_0007915 |
| Disease | Vertigo | 1.92e-03 | 139 | 186 | 5 | HP_0002321 | |
| Disease | Semantic-Pragmatic Disorder | 2.09e-03 | 11 | 186 | 2 | C0454655 | |
| Disease | Tachycardia, Ventricular | 2.09e-03 | 11 | 186 | 2 | C0042514 | |
| Disease | N-acetylphenylalanine measurement | 2.09e-03 | 11 | 186 | 2 | EFO_0800019 | |
| Disease | Auditory Processing Disorder, Central | 2.09e-03 | 11 | 186 | 2 | C0751257 | |
| Disease | Language Delay | 2.09e-03 | 11 | 186 | 2 | C0023012 | |
| Disease | Language Development Disorders | 2.09e-03 | 11 | 186 | 2 | C0023014 | |
| Disease | Speech Delay | 2.09e-03 | 11 | 186 | 2 | C0241210 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.24e-03 | 144 | 186 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | neuroimaging measurement, brain volume measurement | 2.34e-03 | 286 | 186 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | colorectal cancer, endometrial neoplasm | 2.36e-03 | 42 | 186 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.50e-03 | 12 | 186 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.57e-03 | 291 | 186 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | eosinophil count | BNC2 CRTC3 LIMA1 CARMIL2 MTF2 MAP3K14 ERN2 IHO1 SLC9A2 MDN1 RASAL3 PIK3C2B ANAPC1 PCNX1 AKAP13 TMEM131 ATM PIK3R5 ALPK2 | 2.81e-03 | 1488 | 186 | 19 | EFO_0004842 |
| Disease | reticulocyte measurement | PAQR9 CDKN3 BNC2 ARHGEF28 SPTB ASH1L BCL11A KAT2B UBE2O SPIN2A AKAP13 TMEM131 EIF2AK1 ARHGAP21 MED12 | 2.87e-03 | 1053 | 186 | 15 | EFO_0010700 |
| Disease | Neurodevelopmental Disorders | 2.88e-03 | 93 | 186 | 4 | C1535926 | |
| Disease | Anemia, Hemolytic, Acquired | 2.95e-03 | 13 | 186 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 2.95e-03 | 13 | 186 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 2.95e-03 | 13 | 186 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 2.95e-03 | 13 | 186 | 2 | C0221021 | |
| Disease | skin melanoma (is_marker_for) | 2.95e-03 | 13 | 186 | 2 | DOID:8923 (is_marker_for) | |
| Disease | testosterone measurement | TRPM6 DDR1 DCHS2 LIMA1 ANK2 ZNF280D STAG1 KNSTRN DOK7 CEP68 KAT2B ANAPC1 AUTS2 MACF1 ZNF799 ARHGAP21 MED12 | 3.02e-03 | 1275 | 186 | 17 | EFO_0004908 |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.13e-03 | 225 | 186 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 3.27e-03 | 227 | 186 | 6 | EFO_0020946 | |
| Disease | household income | 3.27e-03 | 304 | 186 | 7 | EFO_0009695 | |
| Disease | apolipoprotein B measurement | PAQR9 ANKRD31 BNC2 DCHS2 CRTC3 LIMA1 STAG1 DOK7 KRI1 NFE2L3 USP1 | 3.37e-03 | 663 | 186 | 11 | EFO_0004615 |
| Disease | actinic keratosis | 3.42e-03 | 14 | 186 | 2 | EFO_0002496 | |
| Disease | Malignant neoplasm of breast | AKAP6 NCOA2 ANK2 SYNE1 SPTAN1 OBSCN BCL11A KCNIP3 SLC9A2 WDCP MACF1 ATM HERC2 SPEN MED12 | 3.45e-03 | 1074 | 186 | 15 | C0006142 |
| Disease | Cardiomyopathy, Dilated | 3.46e-03 | 48 | 186 | 3 | C0007193 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 3.67e-03 | 49 | 186 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 3.89e-03 | 50 | 186 | 3 | C1449563 | |
| Disease | disease recurrence, colon carcinoma | 4.11e-03 | 51 | 186 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | ovarian carcinoma | 4.40e-03 | 321 | 186 | 7 | EFO_0001075 | |
| Disease | autism spectrum disorder (is_implicated_in) | 4.47e-03 | 16 | 186 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | smoking cessation | 4.71e-03 | 325 | 186 | 7 | EFO_0004319 | |
| Disease | Dupuytren Contracture | 4.92e-03 | 108 | 186 | 4 | EFO_0004229 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | AKAP6 MORC1 BNC2 FOXP2 DOCK10 BCL11A TMEM71 RYR2 TENM4 ALMS1 TNRC6A AUTS2 | 5.03e-03 | 801 | 186 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Benign neoplasm of stomach | 5.05e-03 | 17 | 186 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.05e-03 | 17 | 186 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 5.05e-03 | 17 | 186 | 2 | C0154060 | |
| Disease | major depressive disorder (is_implicated_in) | 5.05e-03 | 17 | 186 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | 1-Methylhistidine measurement | 5.05e-03 | 17 | 186 | 2 | EFO_0021543 | |
| Disease | corneal topography | 5.08e-03 | 109 | 186 | 4 | EFO_0004345 | |
| Disease | intraocular pressure measurement | 5.19e-03 | 509 | 186 | 9 | EFO_0004695 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 5.25e-03 | 110 | 186 | 4 | EFO_0803335 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 5.35e-03 | 56 | 186 | 3 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 5.62e-03 | 57 | 186 | 3 | EFO_0022284 | |
| Disease | Congenital Fiber Type Disproportion | 5.66e-03 | 18 | 186 | 2 | C0546264 | |
| Disease | hair colour measurement | TNIK BNC2 DOCK10 ZNF831 LYST ZNF750 TENM4 PCNX1 AKAP13 HERC2 | 5.86e-03 | 615 | 186 | 10 | EFO_0007822 |
| Disease | triglycerides to total lipids in small VLDL percentage | 5.90e-03 | 58 | 186 | 3 | EFO_0022338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSSSFSDVETHFRTS | 426 | Q6N043 | |
| SDHSSSGNDRDSVRS | 451 | Q8N350 | |
| HTDSSTDESARRSSS | 606 | Q5RHP9 | |
| SSRDPLSDSSAHAVS | 186 | Q9HCM7 | |
| SSGSLNARSSAEDRS | 726 | Q7Z3E2 | |
| SHGSSSLEHRSEDST | 1291 | O15013 | |
| KLESESDNHRSSSDF | 921 | Q9NR48 | |
| HASGDRSEVSSLSSE | 771 | Q8TDY4 | |
| SLSARDASSSHRGRN | 201 | O43822 | |
| DHDLNRTFTSSFLNS | 66 | Q96HD9 | |
| SDRSSSEDEHSAGRS | 196 | Q9NXE8 | |
| SSLRLSAHRLNSDSG | 2056 | Q15878 | |
| DVTDHGTAARSNLTS | 646 | Q76N32 | |
| RENESSDSSTNRHID | 256 | Q68DQ2 | |
| SSSIHSSRESDAGSD | 971 | Q6ZN30 | |
| TTAAATGRSSHADAR | 586 | Q86TB3 | |
| DIHASSSLNGRSTEE | 251 | Q5T8D3 | |
| SLTHLDASRNVFSRT | 431 | Q6F5E8 | |
| SFSLHASSFESSDSR | 71 | Q8NEN0 | |
| STAARHSRLESSDGD | 56 | Q08345 | |
| SSSSTDDTASLDRHS | 1471 | Q12802 | |
| SGTLDERFHSLDAAS | 3061 | Q8TCU4 | |
| SEFNFDLHTVSSRSL | 3081 | Q8TCU4 | |
| AAAEATRLHQSASSS | 641 | O15085 | |
| FDVATSSREHSLHSN | 186 | A0A1B0GVH6 | |
| SSTASRETLQALHDR | 751 | A5YM72 | |
| SSESQRSRHGSVLSS | 326 | P49238 | |
| LHAQLRDLTSSSSDE | 121 | P78545 | |
| HRRSSSSRSQDSAEG | 476 | Q92625 | |
| TSSSSSEDEQHFERR | 361 | Q6PL18 | |
| DSSRQSGTRHAETSS | 351 | P20930 | |
| RDSSRHSASQEGQDT | 501 | P20930 | |
| RTSRHQGSSVSQDSD | 1261 | P20930 | |
| SERHSDDSERLSGSA | 1276 | P20930 | |
| SSRHSASQDGQDTIR | 1476 | P20930 | |
| SAESSRQSGTRHAET | 1646 | P20930 | |
| ADSSRQSGTRHTESS | 1971 | P20930 | |
| SRGQAASSHEQARSS | 1986 | P20930 | |
| ARDSSRHSTSQEGQD | 2446 | P20930 | |
| RNEEQSGDSSRHSVS | 3166 | P20930 | |
| SSQGRDSHSSSLSEQ | 181 | Q9UKI2 | |
| HLRGNDSADSAVSTD | 381 | Q6ZP65 | |
| ADNSRDDSSSHSGSE | 421 | Q9UHB7 | |
| RTEGTAHSSNTSDVD | 441 | Q9Y483 | |
| SFSVHSDRESSITND | 1406 | Q6ZS30 | |
| RAGSSEFDSEHNLTS | 941 | Q86YV0 | |
| HESLSSFELSASRRG | 606 | Q86VD1 | |
| QRHSSVSRLADSSDL | 1251 | Q14207 | |
| SFRRSATSLESESDH | 766 | Q8N1W1 | |
| ATSLESESDHNSCRS | 771 | Q8N1W1 | |
| EENRFSFRHSTSVSS | 911 | Q9H1A4 | |
| SFRHSTSVSSLAERL | 916 | Q9H1A4 | |
| SDSLRSFSSDRSHTL | 896 | Q01484 | |
| IDSSSLSHQERSRES | 1311 | Q8N7Z5 | |
| ETTRFSSNPSRDSHT | 826 | Q99102 | |
| TSGHESNSTQSRIRE | 246 | Q5D862 | |
| TGRQRSSHSESSDSE | 1646 | Q5D862 | |
| RTTGRQRSSHSESSD | 2171 | Q5D862 | |
| QRSSHSESSDSEVHS | 2176 | Q5D862 | |
| HTDSSESDGTSRRSA | 26 | O95251 | |
| SAVSRHSSFGESVSL | 556 | Q14667 | |
| LESTESRSSFSQHAR | 421 | P02545 | |
| AANHDLTDTTRADLS | 76 | Q96II8 | |
| RIAHSFDSSSLSASL | 556 | Q9NU22 | |
| NHTHRSLFSVESDDT | 641 | Q9Y561 | |
| SRDQRSTSVDHSSTD | 1591 | Q9BY89 | |
| LGAESHTDSLRNSST | 81 | Q9UHB6 | |
| ETNFLSAHSARDEAA | 471 | Q92831 | |
| SHTANRSKFSIADED | 1671 | Q38SD2 | |
| SRTSRLHSLGQSSDA | 86 | Q93015 | |
| SCLDFEQHSRERSAS | 1036 | O95714 | |
| SEDHLSSRSQSILDS | 156 | Q8IYA8 | |
| SHSSSERFLEQSHSS | 401 | P31152 | |
| QHSRRATDQGTTEST | 891 | A6NM62 | |
| SQDAQSLHSGASRRS | 476 | Q76MJ5 | |
| LGRSRHSSSQSDLTS | 4126 | Q2LD37 | |
| SSGRSSHLTNSIEEA | 286 | Q13387 | |
| SSSEHSSENGSLRFS | 686 | Q9H165 | |
| SSEQLHGRSESFSSE | 1591 | Q9P219 | |
| RSSHRSQPSSGDEDS | 806 | Q9UKJ3 | |
| RRASNICDTDSHVSS | 901 | Q96RV3 | |
| SIRNTSIHDDSDSSN | 221 | Q8N4E4 | |
| LRGSDALSETSSVSH | 711 | Q6P996 | |
| ISRHDDEATRTSTSE | 11 | Q9H8E8 | |
| SSVLSARRDSSSHEE | 321 | O15409 | |
| ESRNERHLNGTDTSF | 246 | Q9Y4A8 | |
| STRHSANCDRLSESS | 351 | Q8N5Y2 | |
| GFHRSSSRERLSDSS | 196 | Q8WXX7 | |
| DTDRDNSSLTGTLLH | 866 | Q96JK2 | |
| SSTRSESGTDLREHS | 136 | Q12986 | |
| SSSALTESSGHLDHR | 171 | O94854 | |
| SDFHRSRKSFSSSDR | 491 | Q8NEV8 | |
| RERHFSESTSIDNAL | 1816 | Q8NEV8 | |
| AHSQSAEAERRANTS | 1336 | P55268 | |
| SDGETSNHRLQETSS | 136 | Q8N9T8 | |
| STDARTHSLDNRSQD | 871 | Q8IWU2 | |
| EDLRAFNLHSLSSES | 1296 | Q8IWU2 | |
| HSFERSDFSNSLDSL | 466 | Q93074 | |
| TSHDSRDSSDLQSSH | 301 | Q6X4W1 | |
| SQNSDLSRVSDSGSH | 201 | Q96N21 | |
| SHSALQSELSAEARR | 576 | A2A3K4 | |
| AHDLTFRTSSASEQE | 961 | Q9Y5S2 | |
| THSRLGNSSRDSLDV | 321 | Q6PEW0 | |
| EQDKSHSNSSTLSDR | 356 | Q2PPJ7 | |
| HSNSSTLSDRRLSNS | 361 | Q2PPJ7 | |
| SLIDLAGSERASSTH | 251 | Q86Y91 | |
| AASGAARNSHSAASR | 21 | Q6ZVX9 | |
| ETTSAFHEANLERSS | 2131 | P16112 | |
| SDDRLTLSFASRTHT | 1346 | O00750 | |
| TSNTLDREARSQHTF | 1991 | Q6V1P9 | |
| SSHSNASHARLISDQ | 201 | Q7RTS6 | |
| QSSDDHLNKRSRSSS | 356 | A8CG34 | |
| SRSRSGSDSDDDDSH | 826 | O75400 | |
| QRSESRSASEHSSSA | 846 | O75400 | |
| RSASEHSSSAESERS | 851 | O75400 | |
| ERSSLSLHSLSEGDD | 806 | Q2TAC6 | |
| ELARTGDADLSHTSS | 4791 | Q5VST9 | |
| RSSQSELSADFEHQA | 676 | Q5VYJ5 | |
| SSITRSHSFNRAVDL | 236 | Q9H7U1 | |
| ASSLQDHSRLTSLSR | 91 | Q9NRJ2 | |
| SRSTTPANLDSESEH | 1881 | Q13315 | |
| LSTSAAAHAASRSQA | 26 | O43837 | |
| DRTSTFDPSHSDNLL | 6 | Q9P2G3 | |
| SSDHTTNRFGDRESS | 686 | Q5SW24 | |
| VNHADSRASLASLDS | 1281 | Q96BY6 | |
| RRNSHLEESFTSTEE | 346 | Q9BQI3 | |
| ALNRTNSDSALHTSA | 156 | Q6UUV7 | |
| LHNSRGTSSSDVSAN | 4506 | Q8TDW7 | |
| SNISNSRHDSDEISG | 581 | A2RUB6 | |
| RTTANHDSENLTDSL | 2561 | Q99698 | |
| DTSSRSHIFRRESNE | 416 | Q9H992 | |
| SSSLNRRDSNLHSST | 221 | Q8IWC1 | |
| SSDTESNRHKLSSGL | 961 | O15021 | |
| LTDNSHSEATRAEAA | 331 | Q1MX18 | |
| RESHEALASSSNSSS | 101 | Q9BSE4 | |
| SSSFSELCHRRNTSV | 226 | Q5T8I3 | |
| SSVHSATSDDRFLSR | 176 | P57679 | |
| RSLSSSSSEASHLDV | 261 | Q18PE1 | |
| SSSEASHLDVSASSR | 266 | Q18PE1 | |
| AALDSRSHTSSNSTE | 541 | O94868 | |
| LAAHLSSRDSQSRSV | 196 | Q16667 | |
| DSSDSELELSTVRHQ | 61 | Q9Y2W7 | |
| DGISLSRSQHEESRT | 401 | Q92736 | |
| VSRHEASLSSDSDGL | 971 | Q5VW36 | |
| LAASRDLSTSFQESH | 581 | Q6UXH9 | |
| STGQRRLHSLSTSSD | 346 | Q9BZF2 | |
| RLHSLSTSSDTTADS | 351 | Q9BZF2 | |
| SLATRTDQDSRTALH | 31 | O75832 | |
| ASQSSRDTLSSGVHS | 816 | Q99558 | |
| DDISLLHESQSDRAS | 11 | Q9Y3C5 | |
| LSSLGSRDSSTEAHR | 216 | Q7RTR8 | |
| HDELREIFNDLSSSS | 216 | Q15545 | |
| LTASERFQENSSDHS | 211 | Q6P5X7 | |
| SAALRASSLDAHEET | 531 | Q8TF05 | |
| DSSHDSARASEGSDS | 481 | Q9UPR3 | |
| SSHERFLSFSSLESL | 1361 | Q8NF91 | |
| SESHTDLTFSRELTN | 616 | O15226 | |
| GTSNSSRLSEFHEAK | 766 | Q5QGS0 | |
| SSVDERSGAQHDSSA | 106 | Q6ZRT6 | |
| GSETLASRQESTTDH | 231 | Q9Y448 | |
| NSSESFEHIARSARD | 781 | Q9Y520 | |
| ISNSASSHEEDNRSE | 346 | Q8TEB7 | |
| SSHEEDNRSETASSG | 351 | Q8TEB7 | |
| SDRVASSHISDANLA | 111 | Q99865 | |
| RSHISTDAHSLNSAA | 531 | Q9UIF7 | |
| FTAASDSDLLAQTHR | 1186 | Q9P2P6 | |
| DSDLLAQTHRSFSLD | 1191 | Q9P2P6 | |
| AQTHRSFSLDSLIDA | 1196 | Q9P2P6 | |
| DEHTASAADTSRLSL | 1411 | Q9P2P6 | |
| ISGTDHNSLDSSLTR | 1246 | Q9ULL5 | |
| LQDSRSLLHAFSTRS | 671 | Q5T5J6 | |
| GSQRDLTHSDSESSL | 511 | Q13586 | |
| ESANRISSSASTAHA | 541 | O94993 | |
| ACRASDSSARSSLHT | 531 | Q7Z5H3 | |
| SETLANARHSDASLT | 776 | Q9UK61 | |
| SERASSSEKNESHSA | 741 | Q13023 | |
| SFLRNRSSSDHEATA | 196 | Q8NBU5 | |
| RDTAAATEAQHLSSE | 321 | Q6ZU45 | |
| NRAENGLSRAHSSSE | 26 | Q16281 | |
| GLSRAHSSSEETSSV | 31 | Q16281 | |
| VSSERADGQSRLHDS | 621 | Q15596 | |
| SEDSDTRQTSHLQAR | 236 | Q5QJE6 | |
| SAFDSKLQHSSARED | 96 | Q32MQ0 | |
| DSSQRLTHDASNIHT | 526 | O94967 | |
| NFKGLSEDTRSTSSH | 171 | Q8IWS0 | |
| ETSHADSFSGSISRE | 886 | Q9UKE5 | |
| TSSDLSNANHRTGVS | 206 | A4D1E1 | |
| SSGNRNESAESTLHS | 551 | Q9BX84 | |
| HASLSNRVSFASDID | 326 | Q8IVF5 | |
| TDTKEARGNSSETSH | 2296 | Q96T58 | |
| SSSASLPFDDRDSNH | 21 | Q9UJ98 | |
| SSSEERDHSRSRSPN | 586 | B3KS81 | |
| EGNHSQSRTSSKESD | 626 | B3KS81 | |
| AERDSLLSTSSLASH | 341 | Q8WYR1 | |
| DSSLNREHRASTSTS | 651 | Q9UBY0 | |
| DSSSNQRATHSARLD | 831 | Q9P2F5 | |
| HSTSDLSDATFSDIR | 676 | Q9P227 | |
| ARAHSDNKDSGLSSL | 1436 | Q9P227 | |
| SDRVASSHISDANLA | 111 | Q9BPZ2 | |
| EAHDAFRSSLSSAQA | 2131 | Q13813 | |
| RKHLFSESNQDSSTS | 501 | Q5T4T6 | |
| SHDRSRTVSASSTGD | 486 | P78362 | |
| SSARHSSEDSDITSL | 1336 | Q92545 | |
| LTVDSHLSRSAEDSF | 1026 | Q6IQ55 | |
| QGLASASRDHTDQTS | 1206 | Q9C0C9 | |
| SASTSLRRHETTHTD | 291 | Q96GE5 | |
| SRANSNLTLTDTEHE | 146 | Q6N022 | |
| SDSQVRAFRHTSTLA | 211 | Q8WVM7 | |
| SAARSSDLRLQTHAD | 1376 | P11277 | |
| HDDDNISTTSGFSSR | 176 | P49790 | |
| LHSSLQALTASESSR | 91 | Q9UFV1 | |
| DSIHSANASERDDIS | 276 | Q07157 | |
| LSFDLSRNTDVNHTS | 856 | Q9BXT5 | |
| AESRDHSQTAGRTLT | 1511 | Q5JPB2 | |
| SLSRSDVFRDSFSHS | 676 | Q9H6R7 | |
| LTSSLDSRRQLFSSH | 1681 | Q5T5U3 | |
| ATETTTRHSQRAADG | 646 | P53814 | |
| HLRDRNSGSSSSLNT | 1651 | Q8NDV7 | |
| SSDQLAHFKGSSSRE | 81 | Q6ZSZ6 | |
| SETSDTTGTHESDRN | 701 | O94782 | |
| TTGTHESDRNKESSD | 706 | O94782 | |
| RSTSSDRQDSRSHSS | 1261 | Q5T200 | |
| HLTDGATLNDRSATS | 1051 | Q5THJ4 | |
| HSSLGSTETTHFRDS | 556 | Q9UKN1 | |
| RSEESTASHSSQDAT | 906 | Q9UKN1 | |
| HFSASSTTLGRSEES | 1621 | Q9UKN1 | |
| THFSASSTTLGRSEE | 3426 | Q9UKN1 | |
| RSEESTASHSSQDAT | 3546 | Q9UKN1 | |
| HFSASSTTLGRSEES | 4261 | Q9UKN1 | |
| SNNSSEELSSALHLS | 11 | Q8N987 |